33
/pt/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Criar
Close
Create a timeline
Public timelines
Library
FAQ
Baixar
Export
Criar uma cópia
Premium
Incorporar ao site
Share
Ocular Therapeutix
Category:
Outro
Atualizado:
5 fev 2020
0
0
262
Autores
Created by
Nathan
Attachments
Comments
Eventos
Founded
Series A $1.17M (Undisclosed Investors)
Series B $6.09 M Pinnacle Ventures SV Health Investors Versant Venture Management
Series C $21.53 M Polaris Partners SV Health Investors Versant Venture Management
Series D $23.79 M Ascension Ventures Baxter Ventures Polaris Partners Sparta Capital Partners SV Health Investors Versant Venture Management
Debt $20 M Flexpoint Ford Silicon Valley Bank
IPO $65 M
Stock Drops 30%
Dextenza Approved
Períodos
Phase 2 Dextenza Post-Surgical Inflammation and Pain
Phase 3 Dextenza Post-Surgical Inflammation and Pain
About & Feedback
Acordo
Privacidade
Biblioteca
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments